Betsy Nguyen, MD is a board-certified cataract and glaucoma specialist with over 20 years of experience in her field. Trained at the prestigious, internationally recognized Jules Stein Eye Institute, at UCLA, Dr. Nguyen then became active in glaucoma research with the USC Doheny Eye Institute.

After earning her medical degree with the highest distinction at the top of her class from UCLA School of Medicine, Dr. Nguyen went on to UCSF for her fellowship in glaucoma. A diplomate of the American Academy of Ophthalmology and the California Academy of Eye Physicians & Surgeons, she was a team eye doctor for both the Los Angeles Angels and the Anaheim Ducks.

Dr. Betsy Nguyen is an ardent researcher, to further treatment options available for all, and has extensive expertise in managing glaucoma and cataracts together. These commonly concomitant conditions are best treated together—treating one and ignoring the other will result in long-term problems for patients. Dr. Nguyen uses the most advanced technologies available to combine the treatment in an integrated fashion, offering patients with cataracts and glaucoma the very latest in surgery and research.

​​​​​​​Customizing care to every one of her patients, Dr. Nguyen remains passionate about what she does and spends quality time counseling each one. “I give every patient the same level of attention and surgical excellence I would give my own family.”

EDUCATION

1991 Bachelor of Science, Biological Sciences, University of California, Irvine, CA
1995 Doctor of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA

PROFESSIONAL TRAINING

1995-1996 Internship, Preliminary Medicine, University of California, San Fernando Valley, CA
1996-1999 Residency, Ophthalmology, Jules Stein Eye Institute, University of California, Los Angeles, CA

FELLOWSHIPS

1999-2000 Clinical Fellowship, Glaucoma and Clinical Instructor; University of California, San Francisco, CA
and California Pacific Medical Center

BOARD CERTIFICATION

1997 Medical Board of California
2000 American Board of Ophthalmology

PROFESSIONAL AFFILIATIONS

• American Academy of Ophthalmology

• American Society of Cataract and Refractive Surgery

• American Medical Association

• California Medical Association

• California Academy of Eye Physicians & Surgeons

• Memorial Physician Society

• Orange County Ophthalmology Society

• Orange County Glaucoma Society

Peer Reviewed Publications

• 2018 -Present Principle Investigator, Glaukos Travaprost IDose Phase 3 Clinical Study

• 2017 -2018 Sub-Investigator, CyPass Post-Approval Clinical Study

• ​​​​​​​2013 Researcher for USC – Collaboration with Chinese American Eye Study (CHES). Collaborate with Rohit Varma, MD.

• 2012 Baseline risk factors that predict the development of open-angle glaucoma in a population: The Los Angeles Latino Eye Study. Ophthalmology. 2012 Nov;19(11):2245-53.

• 2012 Four-year incidence of open-angle glaucoma and ocular hypertension: The Los Angeles Latino Eye Study. Am J Ophthalmol. 2012 Aug;154(2):315-325.

• 2011 “Population and High Risk Group Screening for Glaucoma: The Los Angeles Latino Eye Study”, Invest Ophthalmol Vis Sci. 2011 August; 52(9): 6257–6264.

• 2000-2011 Researcher for USC – Collaboration with Los Angeles Latino Eye Study (LALES). Collaborate with Rohit Varma, MD and Brian Francis, MD.

• 2005 Screening for Glaucomatous Optic Nerve Damage: The Los Angeles Latino Eye Study. ARVO Abstract. Invest Ophthalmol Vis Sci 2005;46: E-Abstract 2499.

• 2004 “Prevalence of open-angle glaucoma and ocular hypertension in Latinos: the Los Angeles Latino Eye Study,” Ophthalmology, 2004 Aug; 111(8):1439-48.

• 2003 Prevalence of Open-Angle Glaucoma and Ocular Hypertension in Latinos. The Los Angeles Latino Eye Study (LALES). ARVO Abstract. Invest Ophthalmol Vis Sci 2003;44: E-Abstract 317

• 2007-2009 Schering study (LOCS III Certified)

• 2004-2006 TAKEDA study (LOCS III Certified)

• 2003 Advanced Glaucoma Training DVD, for Allergan

• 1999-2000 Evaluation of computerized optic discs to determine stability vs. progression of glaucoma, under Robert L. Stamper, MD, Chief of Glaucoma, UCSF.

• 1998-1999 Retrospective longitudinal study of progression of glaucoma, using multivariate analysis of serial visual fields, stereoscopic disc photographs, and confocal laser imaging, under Joseph Caprioli, MD, Chief of Glaucoma, UCLA Jules Stein Eye Institute. ARVO paper presentation, “Identification of Glaucoma Progression Through Combined Use of Quantitative Structural and Functional Measures,” May 1999.

• 1995-1997 Development of quantitative methods for evaluation of socket motility of orbital implants, under Robert A. Goldberg, MD, Chief of Oculoplastics, UCLA Jules Stein Eye Institute. Poster presentation, Jules Stein Eye Institute Research and Alumni Day, 1998.

• 1992-1993 Investigation of traumatic optic neuropathy in a rat model, under Robert A. Goldberg, MD & Kenneth Steinsapir, MD, UCLA School of Medicine. Poster presentation, “Dynamic Changes in Cerebral Glucose Metabolism Following Optic Nerve Trauma,” at Neuroscience, 1992.

• 1989-1991 Investigation of the effects of glycation on the function of the sodium-potassium pump, under Margaret H. Garner, PhD, UCI School of Medicine. Publication, “Na,K-ATPase of Cultured Bovine Lens Epithelial Cells: H2O2 Effects,” Experimental Eye Research,

• 1992 Mar, 54 (3): 321-7. Poster presentation, “Glucose Control, by Nonenzymatic Glycation of Na, K-ATPase Function in the Nondiabetic,” FASEB 1991.